These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29745454)

  • 1. Effects of short-term clomipramine on anxiety-like behavior, cellular metabolism, and oxidative stress in primary fibroblast cells of male and female rats.
    Jimenez AG; Winward JD; Smith DM; Ragan CM
    Physiol Rep; 2018 May; 6(9):e13615. PubMed ID: 29745454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular metabolic rates and oxidative stress profiles in primary fibroblast cells isolated from virgin females, reproductively experienced females, and male Sprague-Dawley rats.
    Winward JD; Ragan CM; Jimenez AG
    Physiol Rep; 2018 Oct; 6(20):e13909. PubMed ID: 30350353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the anxiolytic-like effects of clomipramine in two rat strains with different anxiety vulnerability (Wistar and Wistar-Kyoto rats): participation of 5-HT1A receptors.
    Rogel-Salazar G; López-Rubalcava C
    Behav Pharmacol; 2011 Apr; 22(2):136-46. PubMed ID: 21301323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute clomipramine exposure elicits dose-dependent surfacing behavior in adult zebrafish (
    Shafiq A; Andrade M; Matthews R; Umbarger A; Petrunich-Rutherford ML
    PeerJ; 2024; 12():e17803. PubMed ID: 39040938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress.
    Liu Q; Yu J; Mao-Ying QL; Mi WL; Li B; Wang YQ; Wang J; Wu GC
    Pharmacogenomics J; 2008 Dec; 8(6):375-83. PubMed ID: 18195730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in novelty-seeking predict differential responses to chronic antidepressant treatment through sex- and phenotype-dependent neurochemical signatures.
    Pitychoutis PM; Pallis EG; Mikail HG; Papadopoulou-Daifoti Z
    Behav Brain Res; 2011 Sep; 223(1):154-68. PubMed ID: 21549763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postnatal treatment with clomipramine induces female sexual behavior and estrous cycle impairment.
    Molina-Jiménez T; Limón-Morales O; Bonilla-Jaime H
    Pharmacol Biochem Behav; 2018 Mar; 166():27-34. PubMed ID: 29407872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
    Leggio GM; Micale V; Drago F
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):271-7. PubMed ID: 17804207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oxidative stress on the pharmacokinetics of clomipramine in rats treated with ferric-nitrilotriacetate.
    Kobuchi S; Fukushima K; Aoyama H; Matsuda T; Ito Y; Sugioka N; Takada K
    Drug Metab Lett; 2011 Dec; 5(4):243-52. PubMed ID: 22022866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a key-role for histamine from mast cells in the analgesic effect of clomipramine in rats.
    Arrigo-Reina R; Chiechio S
    Inflamm Res; 1998 Feb; 47(2):44-8. PubMed ID: 9535540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. French University Antidepressant Group.
    Caillard V; Rouillon F; Viel JF; Markabi S
    Acta Psychiatr Scand; 1999 Jan; 99(1):51-8. PubMed ID: 10066007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: sex differences exposed.
    Pitychoutis PM; Dalla C; Sideris AC; Tsonis PA; Papadopoulou-Daifoti Z
    Neuroscience; 2012 May; 210():152-67. PubMed ID: 22441040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of serotonergic drugs: focus on OCD.
    Marazziti D; Avella MT; Basile L; Mucci F; Dell'Osso L
    Expert Opin Drug Metab Toxicol; 2019 Apr; 15(4):261-273. PubMed ID: 30793987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?
    Pitychoutis PM; Griva E; Ioannou K; Tsitsilonis OE; Papadopoulou-Daifoti Z
    Int J Neuropsychopharmacol; 2009 Oct; 12(9):1157-63. PubMed ID: 19698192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic interaction between fluoxetine and clomipramine: a case report.
    Balant-Gorgia AE; Ries C; Balant LP
    Pharmacopsychiatry; 1996 Jan; 29(1):38-41. PubMed ID: 8852534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does oxidative stress contribute in tricyclic antidepressants-induced cardiotoxicity?
    El-Demerdash E; Mohamadin AM
    Toxicol Lett; 2004 Sep; 152(2):159-66. PubMed ID: 15302097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular metabolism and oxidative stress as a possible determinant for longevity in small breed and large breed dogs.
    Jimenez AG; Winward J; Beattie U; Cipolli W
    PLoS One; 2018; 13(4):e0195832. PubMed ID: 29694441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.
    Diniz JB; Shavitt RG; Pereira CA; Hounie AG; Pimentel I; Koran LM; Dainesi SM; Miguel EC
    J Psychopharmacol; 2010 Mar; 24(3):297-307. PubMed ID: 19164490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
    Suhara T; Takano A; Sudo Y; Ichimiya T; Inoue M; Yasuno F; Ikoma Y; Okubo Y
    Arch Gen Psychiatry; 2003 Apr; 60(4):386-91. PubMed ID: 12695316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.